SRZN
Surrozen, Inc./DE
Surrozen, Inc./DE (SRZN) has 9 SEC Form 4 filings (13 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 25, 2026.
Insiders have net sold $3.7M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Craig C. Parker
- Employees:40
- HQ:South San Francisco, CA, US
- IPO:2021-01-11
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.7M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$229.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
TCG Crossover GP II, LLCFirst filing | 10% Owner | Sale | 162,500 | $3.5M | Jul 25 | SEC ↗ |
Li YangFirst filing | Exec. Vice President, Research | Sale | 1,584 | $53K | May 5 | SEC ↗ |
Williams Charles OFirst filing | Chief Operating Officer | Sale | 2,036 | $68K | May 5 | SEC ↗ |
Parker Craig CFirst filing | Chief Executive Officer | Sale | 4,524 | $151K | May 5 | SEC ↗ |
Related companies
Surrozen, Inc./DE is in the Healthcare sector.